Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Roselli

Showing results (121-130 of 164) with videos related to

Pageof 17
Sort By:
Anticancer Research|August 1, 2018
Prognostic Significance of Neutrophil-to-lymphocyte Ratio in the Framework of the 8th TNM Edition for Breast CancerPatrizia Ferroni, Mario Roselli, Oreste C Buonomo, et al.
Current Medicinal Chemistry|April 18, 2017
Sex-Genetic Interaction in the Risk for Cerebrovascular DiseaseDonatella Pastore, Francesca Pacifici, Barbara Capuani, et al.
Cancers|June 10, 2022
Immune Response in Vitamin D Deficient Metastatic Colorectal Cancer Patients: A Player That Should Be Considered for Targeted Vitamin D SupplementationCristina Morelli, Michela Rofei, Silvia Riondino, et al.
Frontiers in Endocrinology|November 22, 2019
Insulin Resistance as a Risk Factor for Cutaneous Melanoma. A Case Control Study and Risk-Assessment NomogramsAlessandro Scoppola, Lidia Strigari, Agnese Barnabei, et al.
The International Journal of Biological Markers|May 17, 2011
RFID as a new ICT tool to monitor specimen life cycle and quality control in a biobankUmberto Nanni, Antonella Spila, Silvia Riondino, et al.
Tumori|September 21, 2016
Bevacizumab as first-line treatment in HER2-negative advanced breast cancer: pros and consValentina Sini, Alessandra Cassano, Domenico Corsi, et al.
Cancers|September 14, 2024
Investigating Physical, Social, Emotional, and Health Frailties of Cancer Survivors after Cancer Treatment: The Urgent Call for Tailored Multidisciplinary Survivorship Plans in ItalyStefania Moramarco, Luigi De Angelis, Laura Bernardini, et al.
International Journal of Cancer|August 10, 2019
CD16-158-valine chimeric receptor T cells overcome the resistance of KRAS-mutated colorectal carcinoma cells to cetuximabRoberto Arriga, Sara Caratelli, Giulia Lanzilli, et al.
Journal of Clinical Medicine|January 1, 2021
Clinical Utility of Plasma KRAS, NRAS and BRAF Mutational Analysis with Real Time PCR in Metastatic Colorectal Cancer Patients-The Importance of Tissue/Plasma Discordant CasesVincenzo Formica, Jessica Lucchetti, Elena Doldo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2012
Brachyury, a driver of the epithelial-mesenchymal transition, is overexpressed in human lung tumors: an opportunity for novel interventions against lung cancerMario Roselli, Romaine I Fernando, Fiorella Guadagni, et al.
Pageof 17

Showing results (121-130 of 164) with videos related to

Sort By:
Pageof 17
Anticancer Research|August 1, 2018
Prognostic Significance of Neutrophil-to-lymphocyte Ratio in the Framework of the 8th TNM Edition for Breast CancerPatrizia Ferroni, Mario Roselli, Oreste C Buonomo, et al.
Current Medicinal Chemistry|April 18, 2017
Sex-Genetic Interaction in the Risk for Cerebrovascular DiseaseDonatella Pastore, Francesca Pacifici, Barbara Capuani, et al.
Cancers|June 10, 2022
Immune Response in Vitamin D Deficient Metastatic Colorectal Cancer Patients: A Player That Should Be Considered for Targeted Vitamin D SupplementationCristina Morelli, Michela Rofei, Silvia Riondino, et al.
Frontiers in Endocrinology|November 22, 2019
Insulin Resistance as a Risk Factor for Cutaneous Melanoma. A Case Control Study and Risk-Assessment NomogramsAlessandro Scoppola, Lidia Strigari, Agnese Barnabei, et al.
The International Journal of Biological Markers|May 17, 2011
RFID as a new ICT tool to monitor specimen life cycle and quality control in a biobankUmberto Nanni, Antonella Spila, Silvia Riondino, et al.
Tumori|September 21, 2016
Bevacizumab as first-line treatment in HER2-negative advanced breast cancer: pros and consValentina Sini, Alessandra Cassano, Domenico Corsi, et al.
Cancers|September 14, 2024
Investigating Physical, Social, Emotional, and Health Frailties of Cancer Survivors after Cancer Treatment: The Urgent Call for Tailored Multidisciplinary Survivorship Plans in ItalyStefania Moramarco, Luigi De Angelis, Laura Bernardini, et al.
International Journal of Cancer|August 10, 2019
CD16-158-valine chimeric receptor T cells overcome the resistance of KRAS-mutated colorectal carcinoma cells to cetuximabRoberto Arriga, Sara Caratelli, Giulia Lanzilli, et al.
Journal of Clinical Medicine|January 1, 2021
Clinical Utility of Plasma KRAS, NRAS and BRAF Mutational Analysis with Real Time PCR in Metastatic Colorectal Cancer Patients-The Importance of Tissue/Plasma Discordant CasesVincenzo Formica, Jessica Lucchetti, Elena Doldo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2012
Brachyury, a driver of the epithelial-mesenchymal transition, is overexpressed in human lung tumors: an opportunity for novel interventions against lung cancerMario Roselli, Romaine I Fernando, Fiorella Guadagni, et al.
Pageof 17